Anti-VEGF antibody bevacizumab (Avastin) with 5FU/LV as third line treatment for colorectal cancer (Q45000156)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Anti-VEGF antibody bevacizumab (Avastin) with 5FU/LV as third line treatment for colorectal cancer |
scientific article |
Statements
1 reference
Anti-VEGF antibody bevacizumab (Avastin) with 5FU/LV as third line treatment for colorectal cancer (English)
1 reference
C Emmanouilides
1 reference
M Pegram
1 reference
R Robinson
1 reference
R Hecht
1 reference
F Kabbinavar
1 reference
W Isacoff
1 reference
1 November 2004
1 reference
1 reference
Identifiers
1 reference